Cvi Holdings, LLC Cel Sci Corp Put Options Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 16, 2021	SELL	$11.05 - $16.62 $132,600 - $199,440	-12,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $140,280 - $174,480	12,000 New	12,000 $153,000
Q2 2020 Aug 14, 2020	SELL	$9.75 - $17.6 $167,700 - $302,720	-17,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $129,688 - $293,260	17,200 New	17,200 $198,000

7.5M

61.8K

141K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $50.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.